Position history for Duquesne Family Office LLC's holdings in ENLIVEN THERAPEUTICS INC
Final Value
$0
Final Shares
0
Total Value Change
-$9.3M
Total Shares Change
-463,000
Exited |
| 0 |
-100.0% |
| $0 |
| 0.0% |
| $15.55 |
0 |
| 2025-Q3 | Increased | 947,405 | +104.6% | $19.4M | 0.5% | $20.30 | 55 |
| 2025-Q2 | New | 463,000 | — | $9.3M | 0.2% | $20.68 | 46 |